NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE69322 Query DataSets for GSE69322
Status Public on Jun 30, 2015
Title Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq]
Organisms Homo sapiens; Mus musculus
Experiment type Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
Summary Transcription factor-mediated reprogramming is a powerful method to study cell fate changes. In this work, we demonstrate that the transcription factor Gata6 can initiate reprograming of multiple cell types to induced extraembryonic endoderm (iXEN) cells. Intriguingly, Gata6 is sufficient to drive iXEN cells from mouse pluripotent cells and differentiated neural cells. Furthermore, GATA6 induction in human ES (hES) cells also downregulates pluripotency gene expression and upregulates extraembryonic endoderm genes, revealing a conserved function in mediating this cell fate switch. Profiling transcriptional changes following Gata6 induction in mES cells reveals step-wise pluripotency factor disengagement, with initial repression of Nanog and Esrrb, then Sox2 and finally Oct4, alongside step-wise activation of extraembryonic endoderm genes. Chromatin immunoprecipitation and subsequent high-throughput sequencing analysis shows Gata6 enrichment near both pluripotency and endoderm genes, suggesting that Gata6 functions as both a direct repressor and activator. Together this demonstrates that Gata6 is a versatile and potent reprogramming factor that can act alone to drive a cell fate switch from diverse cell types.
 
Overall design (1) Microarray analysis of Gata6 overexpressing cells from 12 to 144 hours of doxycycline treatment in mouse embryonic stem (mES) cells compared to uninduced mES cells, embryo-derived XEN cells and Sox7 overexpressing mES cells after 144 hours of doxycycline treatment. (2) ChIP-seq analysis of Gata6 binding 36 hours following doxycycline treatment. (3) ChIP-seq analysis of Gata6 binding in embryo-derived XEN cells. (4) RNA-seq analysis of GATA6 overexpressing cells following 144 hours of induction in hES cells.
 
Contributor(s) Wamaitha SE, del Valle I, Cho LT, Wei Y, Fogarty NM, Blakeley P, Sherwood RI, Ji H, Niakan KK
Citation(s) 26109048
Submission date May 28, 2015
Last update date May 15, 2019
Contact name Kathy Niakan
E-mail(s) kathy.niakan@crick.ac.uk
Organization name The Francis Crick Institute
Street address Mill Hill
City London
ZIP/Postal code NW7 1AA
Country United Kingdom
 
Platforms (2)
GPL11154 Illumina HiSeq 2000 (Homo sapiens)
GPL13112 Illumina HiSeq 2000 (Mus musculus)
Samples (16)
GSM1697711 G6L1 FLAG-ChIP 36h+d Line1
GSM1697712 G6L1 IP control 36h+d Line1
GSM1697713 G6L1 FLAG-ChIP 36h+d Line2
This SubSeries is part of SuperSeries:
GSE69323 Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells
Relations
BioProject PRJNA285195
SRA SRP058804

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE69322_Gata6_ChIP-seq_peaks_36h_post_dox.xls.gz 773.3 Kb (ftp)(http) XLS
GSE69322_Gata6_ChIP-seq_peaks_XEN_cells.xlsx 383.9 Kb (ftp)(http) XLSX
GSE69322_Gata6_ChIP-seq_peaks_XEN_cells2.xlsx 467.0 Kb (ftp)(http) XLSX
GSE69322_RNA-seq_analysis_GATA6_induction_hESCs.xlsx 6.1 Mb (ftp)(http) XLSX
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap